A viable solution to Spaceflight-Associated Neuro-Ocular Syndrome is critical to ensure astronaut health as the U.S. sets its sights on the Moon and Mars
HOUSTON, Texas – May 12, 2025 – Starlab Space LLC and Balance Ophthalmics have partnered to find a solution for Spaceflight-Associated Neuro-Ocular Syndrome, a condition that describes functional changes to the eyes of astronauts. One in three astronauts on long-duration International Space Station missions experiences symptoms of SANS, including hyperopic shifts, globe flattening, choroidal/retinal folds and cotton wool spots. If not addressed, prolonged microgravity exposure, including during missions to the Moon or Mars, could cause complete and irreversible vision loss for astronauts.
This partnership demonstrates Starlab’s commitment to scientific research and to safe and repeatable space flight experiences. The company aims to enhance astronauts’ way of life today on the International Space Station, while also setting a baseline for further improvement and future use on Starlab. Dual-use technologies are key to this effort, jumpstarting discoveries that can transform humanity both on Earth and in space.
Balance Ophthalmics has developed the first and only non-invasive, non-pharmaceutical way to treat eye pressure. The FYSX™ Ocular Pressure Adjusting Pump features a quiet, compact, portable pump combined with innovative pressure sensing goggles. The device has been granted FDA DeNovo Classification and shown to lower pressure in every patient at every visit while worn.
“While our issues are reversed in space – we need to increase pressure on the eyes rather than lower it – the technology behind Balance Ophthalmics can be a game changer for future space missions and improve our customer experience on Starlab. I’m looking forward to partnering with Balance, addressing this critical concern and exploring the many other benefits of the technology, so that our astronauts can clearly and completely focus on their best work,” said Tim Kopra, Starlab CEO.
In addition to individual research collaborations, Starlab has established a network of science parks in the U.S., Europe and Japan to foster the open exchange of information and solutions between Earth and space.
“Balance Ophthalmics is proud to partner with Starlab to adapt our innovative FSYX ocular pressure adjusting pump to address the unique vision challenges faced by astronauts. Our mission has always been to pioneer transformative, non-invasive solutions for ocular health, and this collaboration exemplifies how our unique physics-based therapy can make a critical contribution in another important area of need. We’re excited to be part of the journey toward safeguarding astronaut vision, enabling safer and more effective missions to the Moon and Mars,” said Dr. John Berdahl, Founder and Chairman of Balance Ophthalmics.
About Starlab
Starlab Space is a U.S.-led, global joint venture among Voyager Technologies, Airbus, Mitsubishi Corporation and MDA Space, with strategic partners including Palantir Technologies, The Ohio State University, Hilton and more. Starlab is developing a next-generation, AI-enabled commercial space station, aiming to ensure continued human presence in low-Earth orbit and a seamless transition of microgravity science and research alongside the retirement of the International Space Station.